ArticleJournal of advanced pharmaceutical technology & research2022
Awareness on hematological malignancies among college students.
Article in Journal of advanced pharmaceutical technology & research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 3 citations in OpenAlex.
- Racial and Socioeconomic Healthcare Disparities in Access to Chimeric Antigen Receptor T (CAR-T) Cell Therapy for Blood Cancers.Cancer medicine · 2026Review
- SKping cell cycle regulation: role of ubiquitin ligase SKP2 in hematological malignancies.Frontiers in oncology · 2024Review
- Cell characterization of extranodal lymphoproliferative disorders.Journal of oral and maxillofacial pathology : JOMFPArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancers of blood arise when the abnormal blood cells undergo uncontrolled growth which outpaces the natural production of normal blood cells, interfering with the cells' normal functions. Leukemia, lymphoma, and myeloma are the three types of blood cancers. The aim of our study is to assess and create awareness of hematological malignancies among college students. A questionnaire was prepared using Google Forms based on the awareness of the Hematological malignancies disinfection methods among dental students in Chennai. It was then circulated among a certain set of participants using an online Google Form link. The participants were asked about their knowledge level regarding hematological malignancies and a majority (68.97%) were aware of the same, whereas 27.59% were not aware and the rest (3.45%) were not sure. When asked about how dental care detects various hematological malignancies, 10.34% of the participants replied as "patient speaks about any abnormality," 75.86% replied as "oral manifestations," and 13.79% replied as "dentists cannot detect hematological malignancies." From the above results and discussion, we can come to the conclusion that most of the dental students who participated in the survey are aware of hematological malignancies and its various types.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.